Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × Ramucirumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 5 Stomach Neoplasms 2 Neoplasm Metastasis 2 Esophageal Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Cancer 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Metastatic Gastric Adenocarcinoma 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Advanced Gastric or EGJ Cancer 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

Rituximab 25 acalabrutinib 14 Cyclophosphamide 13 ibrutinib 12 venetoclax 11 zanubrutinib 9 Magnetic Resonance Spectroscopy 9 pirtobrutinib 8 obinutuzumab 8 glofitamab 8 fludarabine 8 Lenalidomide 8 CT-P10 8 Bendamustine Hydrochloride 8 Specimen Handling 7 Cytarabine 6 Biopsy 6 fludarabine phosphate 5 brexucabtagene autoleucel 4 Vincristine 4 Doxorubicin 4 Prednisone 3 Cyclosporine 3 palbociclib 2 Whole-Body Irradiation 2 Therapeutics 2 Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Leukapheresis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡